Jäger H
KIS - Kuratorium für Immunschwäche, München.
Med Klin (Munich). 1997 Jun 15;92(6):344-6. doi: 10.1007/BF03044775.
The treatment of HIV infection/AIDS has changed dramatically because of a new pathophysiological understanding of this disease. The most important laboratory parameter for the management of antiretroviral therapy is the direct measurement of virus load in plasma. In Germany 11 different medications are available to the patient for reduction of his viral load in blood and possibly tissues, i.e. lymph-nodes. The majority (about 2/3) of physicians begin to treat with double combination therapy. Protease inhibitors are an important addition to the therapeutic arsenal.
由于对艾滋病病毒感染/艾滋病的病理生理学有了新的认识，其治疗方法发生了巨大变化。抗逆转录病毒治疗管理中最重要的实验室参数是直接测量血浆中的病毒载量。在德国，有11种不同的药物可供患者使用，以降低其血液以及可能在组织（即淋巴结）中的病毒载量。大多数（约三分之二）医生开始采用双重联合疗法进行治疗。蛋白酶抑制剂是治疗药物库中的一项重要补充。
